Synaptogenix, Inc.
Synaptogenix, Inc. (SNPX) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · SNPX · as of Jun 9, 2026
Key Statistics
Explore Synaptogenix, Inc. Data
snpx stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 1 · Buy rate: 100.0%
Competitors & Peers
snpx competitorsSNPX
AMTI
APGN
CYCC
GLS
HURAStock Performance
Full HistoryAbout Synaptogenix, Inc.
Synaptogenix, Inc. operates as a biopharmaceutical entity, actively advancing multiple product candidates through both preclinical and clinical development stages. The company's primary focus involves…
what is synaptogenix, inc. · snpx stock overview · synaptogenix, inc. company profile · who is synaptogenix, inc. ceo · snpx NASDAQ · synaptogenix, inc. headquarters · synaptogenix, inc. business segments
About Stock Overview & Key Data
Synaptogenix, Inc. (SNPX) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Dec 8, 2020. As of the latest trading session, SNPX stock price is $7.85, with a market capitalization of $10.9M. The stock has returned +96.74% over the past 12 months and +121.75% year-to-date.
According to 1 Wall Street analysts, the consensus rating for Synaptogenix, Inc. stock is Buy, with an average 12-month price target of $—. In fiscal year 2025, Synaptogenix, Inc. reported revenue of — and net income of -$29.1B. For detailed data — including Synaptogenix, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Synaptogenix, Inc. (SNPX) stock price is $7.85. The stock is traded on NASDAQ under the ticker symbol SNPX. The 52-week range is $1.84 – $8.94.